Momordicine-I, a bitter melon bioactive metabolite, displays anti-tumor activity in head and neck cancer involving c-Met and downstream signaling

Subhayan Sur, Robert Steele, T. Scott Isbell, Kalyan Nagulapalli Venkata, Mostafa E. Rateb, Ratna B. Ray*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Momordicine-I, a bitter melon bioactive metabolite, displays anti-tumor activity in head and neck cancer involving c-Met and downstream signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences